ARCHIVES

In Brief: FDA Opens Advisory Committee Consideration Of NDAs, Finds Discussion Is Not Inhibited

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

Excerpts Presented From Pepper Hearing

July 20, 1979

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

August 31, 2001

In Brief: Clark Wins Sheen award; Research Training Cuts Prompt PhD Holders To Apply Medical Schools

July 12, 1974

Also MQSA should require mammography facilities to gather data on interpretation, cancer policy board committee says.

May 27, 2005

Monica Bertagnolli Elected Chair Of The Alliance For Clinical Trials In Oncology

July 15, 2011

Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials

March 26, 2004